296 related articles for article (PubMed ID: 9732918)
21. Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.
Llewellyn JG; Pritchard MH
J Rheumatol; 1988 Apr; 15(4):691-4. PubMed ID: 3397979
[TBL] [Abstract][Full Text] [Related]
22. Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stones.
Diehl AK; Schwesinger WH; Holleman DR; Chapman JB; Kurtin WE
Am J Gastroenterol; 1995 Jun; 90(6):967-72. PubMed ID: 7771432
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with celecoxib and rofecoxib utilization.
Rawson NS; Nourjah P; Grosser SC; Graham DJ
Ann Pharmacother; 2005 Apr; 39(4):597-602. PubMed ID: 15755796
[TBL] [Abstract][Full Text] [Related]
24. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence.
Völzke H; Baumeister SE; Alte D; Hoffmann W; Schwahn C; Simon P; John U; Lerch MM
Digestion; 2005; 71(2):97-105. PubMed ID: 15775677
[TBL] [Abstract][Full Text] [Related]
25. The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis.
Lapane KL; Spooner JJ; Pettitt D
Am J Manag Care; 2001 Apr; 7(4):402-8. PubMed ID: 11310194
[TBL] [Abstract][Full Text] [Related]
26. [An echographic study of the prevalence of gallstone disease in Maastricht and the surrounding area].
Thijs CT; van Engelshoven JM; Knipschild PG
Ned Tijdschr Geneeskd; 1989 Jan; 133(3):110-4. PubMed ID: 2646545
[TBL] [Abstract][Full Text] [Related]
27. Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs.
El-Serag HB; Sonnenberg A
Am J Gastroenterol; 1997 Jan; 92(1):52-6. PubMed ID: 8995937
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
[TBL] [Abstract][Full Text] [Related]
29. Cholelithiasis, cholecystectomy, and cancer: a case-control study in Sweden.
Lowenfels AB; Domellöf L; Lindström CG; Bergman F; Monk MA; Sternby NH
Gastroenterology; 1982 Sep; 83(3):672-6. PubMed ID: 7095370
[TBL] [Abstract][Full Text] [Related]
30. Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.
Friedrich N; Völzke H; Hampe J; Lerch MM; Jørgensen T
Am J Gastroenterol; 2009 Jan; 104(1):89-95. PubMed ID: 19098855
[TBL] [Abstract][Full Text] [Related]
31. [The Boario project. A study of the prevalence of lithiasis in a spa population].
Rusticali AG; Sama C; Morselli Labate AM; Frabboni R; Nacchiero MC; Tassinari G; Barbara L
Minerva Med; 1990 Apr; 81(4):301-6. PubMed ID: 2188169
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
Hepatology; 1988; 8(4):904-6. PubMed ID: 3391519
[TBL] [Abstract][Full Text] [Related]
33. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
34. Drug-associated cholelithiasis: a case of sulindac stone formation and the incorporation of sulindac metabolites into the gallstones.
Tokumine F; Sunagawa T; Shiohira Y; Nakamoto T; Miyazato F; Muto Y
Am J Gastroenterol; 1999 Aug; 94(8):2285-8. PubMed ID: 10445564
[TBL] [Abstract][Full Text] [Related]
35. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
36. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
Stroffolini T; Sagnelli E; Mele A; Cottone C; Almasio PL;
J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
[TBL] [Abstract][Full Text] [Related]
37. Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas.
Martin C; Connelly A; Keku TO; Mountcastle SB; Galanko J; Woosley JT; Schliebe B; Lund PK; Sandler RS
Gastroenterology; 2002 Dec; 123(6):1770-7. PubMed ID: 12454832
[TBL] [Abstract][Full Text] [Related]
38. NSAID use and progression of chronic kidney disease.
Gooch K; Culleton BF; Manns BJ; Zhang J; Alfonso H; Tonelli M; Frank C; Klarenbach S; Hemmelgarn BR
Am J Med; 2007 Mar; 120(3):280.e1-7. PubMed ID: 17349452
[TBL] [Abstract][Full Text] [Related]
39. Plasma lipid profile in gallstone patients from North India.
Saraya A; Irshad M; Gandhi BM; Tandon RK
Trop Gastroenterol; 1995; 16(4):16-21. PubMed ID: 8854950
[TBL] [Abstract][Full Text] [Related]
40. Exposure to nonsteroidal anti-inflammatory drugs among older adult patients hospitalized for peptic ulcer disease in Argentina: A case-control study.
Insúa J; Mavros P; Hunsche E; Kong S; Tibaudin-Agver O
Am J Geriatr Pharmacother; 2006 Sep; 4(3):251-9. PubMed ID: 17062326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
